Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based Chemotherapy.
Pelosof L, Saung MT, Donoghue M, Casak S, Mushti S, Cheng J, Jiang X, Liu J, Zhao H, Khazraee M, Goldberg KB, Theoret M, Lemery S, Pazdur R, Fashoyin-Aje L. Pelosof L, et al. Among authors: pazdur r. Oncologist. 2021 Apr;26(4):318-324. doi: 10.1002/onco.13646. Epub 2021 Jan 11. Oncologist. 2021. PMID: 33345396 Free PMC article. Clinical Trial.
Pediatric oncology: regulatory initiatives.
Hirschfeld S, Shapiro A, Dagher R, Pazdur R. Hirschfeld S, et al. Among authors: pazdur r. Oncologist. 2000;5(6):441-4. doi: 10.1634/theoncologist.5-6-441. Oncologist. 2000. PMID: 11110594 Free article.
FDA drug approval summaries: fulvestrant.
Bross PF, Cohen MH, Williams GA, Pazdur R. Bross PF, et al. Among authors: pazdur r. Oncologist. 2002;7(6):477-80. doi: 10.1634/theoncologist.7-6-477. Oncologist. 2002. PMID: 12490735 Free article.
FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.
Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. Cohen MH, et al. Among authors: pazdur r. Oncologist. 2003;8(4):303-6. doi: 10.1634/theoncologist.8-4-303. Oncologist. 2003. PMID: 12897327 Free article. Clinical Trial.
FDA drug approval summaries: oxaliplatin.
Ibrahim A, Hirschfeld S, Cohen MH, Griebel DJ, Williams GA, Pazdur R. Ibrahim A, et al. Among authors: pazdur r. Oncologist. 2004;9(1):8-12. doi: 10.1634/theoncologist.9-1-8. Oncologist. 2004. PMID: 14755010 Free article. Clinical Trial.
FDA drug approval summaries: pemetrexed (Alimta).
Hazarika M, White RM, Johnson JR, Pazdur R. Hazarika M, et al. Among authors: pazdur r. Oncologist. 2004;9(5):482-8. doi: 10.1634/theoncologist.9-5-482. Oncologist. 2004. PMID: 15477632 Free article. Review.
603 results